Artikel ; Online: CCR10-mediated Enhancement of T Cell Trafficking for Improved Tumor Immunotherapy.
2024 Band 44, Heft 2, Seite(n) 521–532
Abstract: Background/aim: The effectiveness of adoptive T cell therapy for solid tumors remains suboptimal, partly attributed to insufficient T cell infiltration into the tumor site. A promising strategy involves directing T cells towards the tumor utilizing ... ...
Abstract | Background/aim: The effectiveness of adoptive T cell therapy for solid tumors remains suboptimal, partly attributed to insufficient T cell infiltration into the tumor site. A promising strategy involves directing T cells towards the tumor utilizing tumor-specific chemokine receptors. Materials and methods: We analyzed chemokine receptor expression in activated T cells and chemokine expression in breast and lung cancer using The Cancer Genome Atlas (TCGA) data. Subsequently, we generated 1G4 T cell receptor-engineered T (TCR-T) cells with CCR10 and performed in vitro and in vivo efficacy tests. Results: CCR10 exhibited insufficient expression in various human T cells. Analysis of TCGA RNA sequencing data revealed elevated expression of the chemokine CCL28, the corresponding chemokine for CCR10, in breast and lung cancer. Consequently, we generated CCR10-1G4 TCR-T cells. CCR10-1G4 dual expressing TCR-T cells exhibited comparable cellular cytotoxicity but increased mobility compared to 1G4 TCR-T cells in vitro. Furthermore, injecting CCR10-1G4 dual expressing TCR-T cells into a xenograft tumor model demonstrated enhanced in vivo trafficking and a greater reduction of tumor burden. Conclusion: This study highlights the potential of CCR10 for developing efficient adoptive T-cell treatments targeting solid tumors. |
---|---|
Mesh-Begriff(e) | Humans ; T-Lymphocytes/metabolism ; Chemokines/metabolism ; Receptors, Chemokine ; Immunotherapy ; Lung Neoplasms/therapy ; Receptors, Antigen, T-Cell/genetics ; Receptors, CCR10/genetics ; Receptors, CCR10/metabolism |
Chemische Substanzen | Chemokines ; Receptors, Chemokine ; Receptors, Antigen, T-Cell ; CCR10 protein, human ; Receptors, CCR10 |
Sprache | Englisch |
Erscheinungsdatum | 2024-02-01 |
Erscheinungsland | Greece |
Dokumenttyp | Journal Article |
ZDB-ID | 604549-2 |
ISSN | 1791-7530 ; 0250-7005 |
ISSN (online) | 1791-7530 |
ISSN | 0250-7005 |
DOI | 10.21873/anticanres.16840 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 1642: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.